Dicerna Pharmaceuticals Inc. (DRNA) Slipped -8.8% or -1.27 To Price $13.17 On Tuesday


Dicerna Pharmaceuticals Inc. (DRNA) slipped -8.8% or -1.27 to $13.17. It is close to 1.25 million shares traded, which is 178.82% compare to the average total volume 698475. The market cap of DRNA is $682.17 million. The year to date change is 54.27%. The 52 week price range is from $2.69 to $15.27. Price of DRNA have changed -3.48% during last week. It have changed 40.06% over last month, 50.42% over last 3 months, 74.82% over last 6 months N/A

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for DRNA is 11.94. It is -9.34% below current price. The 200-day Moving Averages for DRNA is 8.18. It is -37.89% below current price. The 52-week High is 15.27. It is 15.95% from the current price. The 52-week Low is 2.69. It is -79.57% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of DRNA is 1.75 on 2018-04-30. Short % to float is 2.60%. There are some statistics of DRNA. It is has market cap $682.17 million. The share outstanding is 51.80 million. The average volume is 698475. The revenue is 859000. The percent of top 15 Institution holding is 79.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of DRNA is -112.52%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of DRNA is -93.11%.


Tags:

Share this post